glaucoma surgery

Opportunities and challenges in the world of ophthalmology in 2018As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
Exploring safety, efficacy of high-intensity focused ultrasound in glaucomaHigh-intensity focused ultrasound cyclocoagulation is safe and effective in most refractory glaucomatous eyes. Complete success was achieved in 80% (24/30) of treated eyes that had undergone the maximum of three procedures.
ECP provides primary secondary therapy option for glaucomaFor 20 years I have effectively employed endoscopic cyclophotocoagulation (ECP) as a primary or secondary line of glaucoma treatment. ECP is a minimally invasive glaucoma surgical (MIGS) option capable of reducing IOP in the majority of patients and can potentially eliminate the need for drainage surgery, including trabeculectomy (trab) and glaucoma drainage devices (GDDs).
Growing attention turns to cerebrospinal fluid pressure in glaucomaCataract surgery in patients with coexisting uveitis is more challenging than managing either condition alone.
MIGS devices lead glaucoma surgical innovation in 2016A single event stood out in everyone’s mind when Ophthalmology Times asked experts to think back on the year in glaucoma surgery: the July 29 approval by the U.S. Food and Drug Administration (FDA) of the CyPass Micro-Stent.
MIGS making big difference in glaucoma managementMicroinvasive glaucoma surgery devices already have transformed the management of glaucoma and will have a bigger impact in the future considering the options in the investigational pipeline and the opportunities they present.
Know your glaucoma surgery for better comanagement
Know your glaucoma surgery for better comanagementTreating and managing chronic glaucoma can be rewarding as an optometrist. The frequency of office visits to monitor this chronic disease provides ODs an opportunity to develop a close relationship with their patients while providing medical eye care.
Impressive IOP results from second-generation microinvasive surgeryImplantation of two second-generation trabecular micro-bypass stents (iStent inject, Glaukos) as a single procedure or combined with cataract surgery is a safe and effective option for reducing IOP and the medication burden in eyes with open-angle glaucoma and IOP uncontrolled by medication and/or surgery, according to German surgeons.
2015 brings big Medicare changes, small technology changes to glaucoma surgeryThe year 2015 brought a trickle of innovation to the technique of glaucoma surgery, and a tidal wave of change to the business model in the United States.
Supraciliary microstenting: advancing glaucoma treatment in the age of MIGSIn this article, Dr Ianchulev discusses MIGS supraciliary microstenting, a compelling new approach for outflow enhancement that results in sustained reduction of IOP and anti-hypertensive topical medication use in OAG patients.